As can be seen in Figure 1, ILK co-localized with β1-integrin, NHE1, NHERF1 and p-ezrin, principally in areas of focal ECM proteolysis in both breast MDA-MB-231 (Figure 1A) and prostate PC-3 (Figure 1B) cancer cells. The gene discussed is SLC9A1; the disease is cancer.